Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study
Journal of the American Academy of Dermatology · 2024-04 · 90 (4) · 783-789
DOI: 10.1016/j.jaad.2023.12.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2024-04. Verfasst von Luying Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burn and Plastic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China; Department of Bur…. Hauptthemen laut MEDLINE: Hemangioma, Skin Neoplasms, Hemangioma, Capillary. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Relapse of infantile hemangiomas after withdrawal from propranolol treatment is common. Early withdrawal is believed to increase the risk of relapse. OBJECTIVE: The objective of this study was to determine the optimal time to discontinue propranolol treatment for infantile hemangiomas. METHODS: A prospective study conducted at a tertiary referral center. RESULTS: Compared to withdrawal after 1-month maintenance treatment, withdrawal after 3-month maintenance, corresponding achieving maximum regression of infantile hemangiomas, was associated with a lower major relapse rate (P = .041). The relapse (P = .055) and adverse event rates (P = .154) between the 2 withdrawal modes were not statistically significant. Compared with direct withdrawal, the relapse (P = .396), major relapse (P = .963), and adverse event rates (P = .458) of gradual withdrawal were not statistically different. Patients with/without relapse could be best distinguished according to whether withdrawal followed a 3-month maintenance and age >13 months (area under the receiver operating characteristic curve = 0.603). Patients with/without major relapse could be best distinguished according to whether withdrawal was accompanied by 3-month maintenance (area under the receiver operating characteristic curve = 0.610). LIMITATIONS: The limitations of this study are nonrandomization and single-center design. CONCLUSIONS: The optimal propranolol withdrawal time to avoid relapse is when the patient is aged >13 months and the lesion has maintained for 3 months after reaching maximum regression, while the optimal time to prevent major relapse is after 3 months of maintenance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Burn and Plastic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China; Department of Burn and Plastic Surgery, Shandong Provincial Hospital, Cheeloo College o…
- Department of Burn and Plastic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Burn and Plastic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Burn and Plastic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Electronic address: huoran@email.sdu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Wang, W., Zhou, Z., Li, J., Li, Z., Lv, R., Xu, G., Bi, J., & Huo, R. (2024). Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study. Journal of the American Academy of Dermatology, 90(4), 783-789. https://doi.org/10.1016/j.jaad.2023.12.034
Vancouver
Wang L, Wang W, Zhou Z, Li J, Li Z, Lv R, et al. Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study. Journal of the American Academy of Dermatology. 2024;90(4):783-789. doi:10.1016/j.jaad.2023.12.034
BibTeX
@article{Wang2024,
author = {Wang, Luying and Wang, Wenjing and Zhou, Zifu and Li, Jing and Li, Zhiyu and Lv, Renrong and Xu, Guangqi and Bi, Jianhai and Huo, Ran},
title = {Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study},
journal = {Journal of the American Academy of Dermatology},
year = {2024},
volume = {90},
number = {4},
pages = {783--789},
doi = {10.1016/j.jaad.2023.12.034}
}
EUVIMED